International Breakthrough Treatment for Cryptosporidiosis Calf Scours
10 September 2006
Professional Veterinary Distributors Ltd today announced the launch of Kryptade, a new re-hydration electrolyte which
significantly aids recovery of calves from scours caused by cryptosporidiosis.
Scours (diarrhoea) in calves is a serious problem causing rapid fluid loss and sometimes death. It also results in
substantial losses due to time and materials needed for its treatment.
Kryptade, developed in New Zealand by veterinarian Bruce Pauling, is the first product offering farmers a chance to
reduce the scours severity from cryptosporidiosis.
“This product is an international breakthrough,” says Dr Pauling. “Currently there are no products which will directly
assist calves to recover from cryptosporidiosis. Kryptade offers truly unique features to New Zealand farmers. It can be
used to re-hydrate a calf with scours from any nutritional or infectious origin, and there are no downside risks such as
antibiotic resistance.”
Dr Pauling says formulating this extra performance in an electrolyte has been based on a carbohydrate called
betacyclodextrin. Scours, particularly when more than one infectious agent is involved, severely affects the calf’s
desire to take milk. This appetite loss can last for more than five days and impact on the health and growth of calves.
“Kryptade becomes a real winner when treating these calves. The electrolyte is highly palatable, and when calves drink
readily at the same time as they receive a gentle, therapeutic treatment for re-hydration, there is a noticeably faster
rate of recovery and an earlier return to bright and vigorous activity.”
Kryptade is based on the rehydration electrolyte ENERVADE proven in 2005 to be palatable to sick, weakened calves.
Betacyclodextrin has been added to this formulation along with additional amino-acids and seaweed extract. It is a
single mix powder ready to mix with warm water.
Trials carried out in New Zealand have confirmed that natural carbohydrates such as seaweed and amino acids added to
Enervade, combined with betacyclodextrin, limited the severity of scours and reduced the period of treatment. Calves
showed a return to appetite for milk 24 hours earlier than electrolyte-only treated calves. And there was a highly
significant reduction of 40% in volumes of electrolytes for full calf recovery.
Dr Pauling expects farmers will welcome this new product to help overcome what is a serious problem in many calf units.
Kryptade will be available from veterinarians only.
“Being based on carbohydrates with added natural features such as seaweed in an electrolyte base, KRYPTADE has no
withholding period and no tissue residue problems. It is an over-the-counter product requiring no prescription,” he
says.
ENERVADE and KRYPTADE are registered pursuant to the ACVM Act 1997, A9410, and A9621. See www.nzfsa.govt.nz/acvm/ for registration conditions
Ends